Novo Nordisk Executive Vice President of US Operations Jamey Millar says that the company's market research shows twice as many US Medicare recipients would rather take a weight-loss pill over a shot. #weightloss #health #medicine #business
Novo Nordisk Executive Vice President of US Operations Jamey Millar says that the company's market research shows twice as many US Medicare recipients would rather take a weight-loss pill over a shot. #weightloss #health #medicine #business
